Evaluation of histamine H2 receptor blocking activity of a new 2-substituted pyrazinopyridoindole: diphenethindole.
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D004353:Drug Evaluation, Preclinical; D005260:Female; D005750:Gastric Juice / Q000187:drug effects / Q000378:metabolism; D006168:Guinea Pigs; D006339:Heart Rate / Q000187:drug effects; D007211:Indoles / Q000494:pharmacology* / Q000627:therapeutic use; D008297:Male; D011719:Pyrazines / Q000494:pharmacology* / Q000627:therapeutic use; D011817:Rabbits; D051381:Rats; D011968:Receptors, Histamine / Q000378:metabolism*; D011970:Receptors, Histamine H2 / Q000187:drug effects / Q000378:metabolism*; D014456:Ulcer / Q000188:drug therapy
D007211:Indoles; D011719:Pyrazines; D011968:Receptors, Histamine; D011970:Receptors, Histamine H2; C026186:diphenethindole